273 related articles for article (PubMed ID: 37798673)
1. Naloxone prescriptions among patients with a substance use disorder and a positive fentanyl urine drug screen presenting to the emergency department.
Ali SA; Shell J; Harris R; Bedder M
Harm Reduct J; 2023 Oct; 20(1):144. PubMed ID: 37798673
[TBL] [Abstract][Full Text] [Related]
2. Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl.
Carpenter J; Murray BP; Atti S; Moran TP; Yancey A; Morgan B
J Med Toxicol; 2020 Jan; 16(1):41-48. PubMed ID: 31471760
[TBL] [Abstract][Full Text] [Related]
3. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
Kohan LR; Elmofty D; Pena I; Liao C
J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
[TBL] [Abstract][Full Text] [Related]
4. Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose.
Follman S; Arora VM; Lyttle C; Moore PQ; Pho MT
JAMA Netw Open; 2019 May; 2(5):e193209. PubMed ID: 31050777
[TBL] [Abstract][Full Text] [Related]
5. Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial.
Socias ME; Wood E; Le Foll B; Lim R; Choi JC; Mok WY; Bruneau J; Rehm J; Wild TC; Bozinoff N; Hassan A; Jutras-Aswad D;
Addiction; 2022 Oct; 117(10):2662-2672. PubMed ID: 35712892
[TBL] [Abstract][Full Text] [Related]
6. URINE TOXICOLOGY PROFILES OF EMERGENCY DEPARTMENT PATIENTS WITH UNTREATED OPIOID USE DISORDER: A MULTI-SITE VIEW.
Cowan E; Perrone J; Dziura J; Edelman EJ; Hawk K; Herring A; McCormack R; Murphy A; Phadke M; Fiellin DA; D'Onofrio G
J Emerg Med; 2023 Oct; 65(4):e357-e365. PubMed ID: 37716904
[TBL] [Abstract][Full Text] [Related]
7. Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone.
Kline A; Williams JM; Steinberg ML; Mattern D; Chesin M; Borys S; Chaguturu V
J Subst Use Addict Treat; 2023 Jun; 149():209028. PubMed ID: 37003539
[TBL] [Abstract][Full Text] [Related]
8. Disparities in naloxone prescriptions in a University Hospital during the COVID-19 pandemic.
Chieh K; Patel I; Walter L; Li L
Harm Reduct J; 2022 Jul; 19(1):84. PubMed ID: 35883136
[TBL] [Abstract][Full Text] [Related]
9. Patient, prescriber, and Community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18.
Stein BD; Jones CM; Smart R; Sheng F; Sorbero M
Drug Alcohol Depend; 2021 Apr; 221():108569. PubMed ID: 33578296
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for severe respiratory depression from prescription opioid overdose.
Fox LM; Hoffman RS; Vlahov D; Manini AF
Addiction; 2018 Jan; 113(1):59-66. PubMed ID: 28646524
[TBL] [Abstract][Full Text] [Related]
11. Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial.
Jutras-Aswad D; Le Foll B; Ahamad K; Lim R; Bruneau J; Fischer B; Rehm J; Wild TC; Wood E; Brissette S; Gagnon L; Fikowski J; Ledjiar O; Masse B; Socias ME;
Am J Psychiatry; 2022 Oct; 179(10):726-739. PubMed ID: 35702828
[TBL] [Abstract][Full Text] [Related]
12. Fentanyl-contaminated cocaine outbreak with laboratory confirmation in New York City in 2019.
DiSalvo P; Cooper G; Tsao J; Romeo M; Laskowski LK; Chesney G; Su MK
Am J Emerg Med; 2021 Feb; 40():103-105. PubMed ID: 33360606
[TBL] [Abstract][Full Text] [Related]
13. Brief Report: Rates of Fentanyl Use Among Psychiatric Emergency Room Patients.
Elmarasi M; Garcia-Vassallo G; Campbell S; Fuehrlein B
Am J Addict; 2021 Jan; 30(1):92-95. PubMed ID: 32779217
[TBL] [Abstract][Full Text] [Related]
14. Fentanyl analogue overdose: Key lessons in management in the synthetic opioid age.
Raheemullah A; Andruska N
J Opioid Manag; 2019; 15(5):428-432. PubMed ID: 31849033
[TBL] [Abstract][Full Text] [Related]
15. Understanding opioid overdose risk and response preparedness among people who use cocaine and other drugs: Mixed-methods findings from a large, multi-city study.
Hughto JMW; Gordon LK; Stopka TJ; Case P; Palacios WR; Tapper A; Green TC
Subst Abus; 2022; 43(1):465-478. PubMed ID: 34228944
[No Abstract] [Full Text] [Related]
16. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.
Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE
Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535
[TBL] [Abstract][Full Text] [Related]
17. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
[TBL] [Abstract][Full Text] [Related]
18. Naloxone prescriptions following emergency department encounters for opioid use disorder, overdose, or withdrawal.
Kilaru AS; Liu M; Gupta R; Perrone J; Delgado MK; Meisel ZF; Lowenstein M
Am J Emerg Med; 2021 Sep; 47():154-157. PubMed ID: 33812332
[TBL] [Abstract][Full Text] [Related]
19. Impact of naloxone education for patients receiving buprenorphine-containing prescriptions indicated for opioid use disorder at an independent community pharmacy.
Hines KL; Garofoli GK; Garofoli MP; Elswick BM; Winstanley EL
J Am Pharm Assoc (2003); 2020; 60(6):e205-e214. PubMed ID: 32800678
[TBL] [Abstract][Full Text] [Related]
20. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
